TEL/AML/CTD
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TEL/AML/CTD, covering 2024-11-19 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension [Phase 4]